Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021)
Lawler, Patrick R; Golighe, Ewan C; Berge, Jeffrey S; Neal, Matthew D; Mcverry, Bryan J; Nicolau, Jose Carlos 
; Gong, Michelle N; Carrier, Marc; Rosenson, Robert S; Reynolds, Harmony R
Source: New england journal of medicine. Unidade: FM
Subjects: COVID-19, TROMBOSE, ANTICOAGULANTES, PREVENÇÃO DE DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAWLER, Patrick R et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. New england journal of medicine, v. 385, n. 9, p. 790-802, 2021Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa2105911. Acesso em: 04 nov. 2024.APA
Lawler, P. R., Golighe, E. C., Berge, J. S., Neal, M. D., Mcverry, B. J., Nicolau, J. C., et al. (2021). Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. New england journal of medicine, 385( 9), 790-802. doi:10.1056/NEJMoa2105911NLM
Lawler PR, Golighe EC, Berge JS, Neal MD, Mcverry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 [Internet]. New england journal of medicine. 2021 ; 385( 9): 790-802.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1056/NEJMoa2105911Vancouver
Lawler PR, Golighe EC, Berge JS, Neal MD, Mcverry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 [Internet]. New england journal of medicine. 2021 ; 385( 9): 790-802.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1056/NEJMoa2105911
